cleveland clinic glp-1 study reveals what happens when patients stop taking drugs Research from the Cleveland Clinic

46 KorotkovaM.JakobssonP

Non-stimulants like atomoxetine may have different effects, often with less initial appetite suppression but still potential for weight changes due to metabolic or behavioral shifts

Your treatment plan should be monitored and adjusted as needed to ensure the best results

Hyponatraemia has been reported rarely with some sulfonylureas

Among adults who have used these drugs, seven in ten say they used them primarily to treat a chronic condition like diabetes or heart disease (38%) or to both treat a chronic condition and lose weight (32%), while three in ten GLP-1 users (30%) report using these drugs primarily to lose weight